Copyright
©The Author(s) 2021.
World J Clin Pediatr. Jul 9, 2021; 10(4): 48-52
Published online Jul 9, 2021. doi: 10.5409/wjcp.v10.i4.48
Published online Jul 9, 2021. doi: 10.5409/wjcp.v10.i4.48
Table 2 Current Indications for prescribing omalizumab
| Ref. | Age | Previous treatment |
| NICE[4] | > 6 yr | Optimised standard treatment with documented compliance |
| Continuous or 4 or more courses of oral steroids in the previous year | ||
| NICE[5] | > 12 yr | Poor response to standard treatment with H1-antihistamines and leukotriene receptor antagonists |
| Objective severity score (weekly urticaria activity score) > 28 |
- Citation: Doherty S, Mulholland M, Shields M, McCrossan P. Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature . World J Clin Pediatr 2021; 10(4): 48-52
- URL: https://www.wjgnet.com/2219-2808/full/v10/i4/48.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v10.i4.48